Wayne chats with Paul Kim, Principal of Kendall Square Policy Strategies LLC, and Stuart Pape, Senior Partner and Food and Drug Chair at Polsinelli. Together, they discuss the resignation of Dr. Marty Makary as FDA Commissioner, the installment of former Deputy Commissioner of Human Foods Kyle Diamantas as Acting Head of the agency, qualifications of FDA Commissioner, potential timing of a new official Commissioner, and much more. This episode and all bonus episodes do not include the usual Headlines and Resources Links segments. Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@fdawatch.net. Music by Dvir Silver from Pixabay.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from FDA Watch
A Fresh Look at the State of Human Foods
Insights on Evidence and Communication with FDA in Device Submissions
Cautious Optimism Surrounding Rare Diseases and Orphan Drugs
FDA's Regulatory Revisions: Business & Legal Impact on Industry, Part 3 – Foods
Get summaries like this every morning.
Free AI-powered recaps of FDA Watch and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.